Insights into cytomegalovirus-associated T cell receptors in recipients following allogeneic hematopoietic stem cell transplantation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Insights into cytomegalovirus-associated T cell receptors in recipients following allogeneic hematopoietic stem cell transplantation ; volume:21 ; number:1 ; day:30 ; month:9 ; year:2024 ; pages:1-11 ; date:12.2024
Virology journal ; 21, Heft 1 (30.9.2024), 1-11, 12.2024
- Creator
-
Xia, Jintao
Xiao, Yingjun
Gui, Genyong
Gong, Shengnan
Wang, Huiqi
Li, Xuejie
Yan, Ren
Fan, Jun
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12985-024-02511-x
- URN
-
urn:nbn:de:101:1-2412172108002.187302788648
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
08.09.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Xia, Jintao
- Xiao, Yingjun
- Gui, Genyong
- Gong, Shengnan
- Wang, Huiqi
- Li, Xuejie
- Yan, Ren
- Fan, Jun
- SpringerLink (Online service)
Other Objects (12)
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients
Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation
Ageing-resembling phenotype of long-term allogeneic hematopoietic cells recipients compared to their donors
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients - evaluation of pre-transplant risk assessments
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients—evaluation of pre-transplant risk assessments
Impact of graft invariant natural killer T cells on early cytomegalovirus reactivation following allogeneic hematopoietic cell transplantation
Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period
Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation
Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients
Cost Effectiveness of Letermovir for Cytomegalovirus Prophylaxis Compared with Pre-Emptive Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the United States
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients
Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation
Ageing-resembling phenotype of long-term allogeneic hematopoietic cells recipients compared to their donors
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients - evaluation of pre-transplant risk assessments
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients—evaluation of pre-transplant risk assessments
Impact of graft invariant natural killer T cells on early cytomegalovirus reactivation following allogeneic hematopoietic cell transplantation
Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period
Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation
Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients
Cost Effectiveness of Letermovir for Cytomegalovirus Prophylaxis Compared with Pre-Emptive Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the United States
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients
Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation
Ageing-resembling phenotype of long-term allogeneic hematopoietic cells recipients compared to their donors
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients - evaluation of pre-transplant risk assessments
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients—evaluation of pre-transplant risk assessments
Impact of graft invariant natural killer T cells on early cytomegalovirus reactivation following allogeneic hematopoietic cell transplantation
Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period
Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation
Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients